RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial.
EClinicalMedicine
; 63: 102175, 2023 Sep.
Article
in En
| MEDLINE
| ID: mdl-37680942
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Prognostic_studies
Language:
En
Journal:
EClinicalMedicine
Year:
2023
Document type:
Article